Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resolve: RSV F Vaccine in Older Adults
NCT02608502Phase 3Completed
- Sponsor
- Novavax
- Start
- Nov 2015
- Primary completion
- Dec 2016
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of RSV F vaccine + aluminum phosphate in respiratory syncytial virus infection (RSV), sponsored by Novavax. Started Nov 2015; status: completed.
02
Drugs
RSV F vaccine + aluminum phosphate
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02608502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608502.